IRCT20120215009014N301RecruitingPhase 2
Effect of low-dose Naltrexone versus placebo in the treatment of chronic plaque psoriasis: a double-blind randomized clinical trial
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 154
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 65 years (—)
- Sex
- All
Inclusion Criteria
- •Age of 18 to 65 years,
- •Chronic plaque psoriasis
Exclusion Criteria
- •Pregnancy or breastfeeding,
- •Addiction to opium,
- •Renal or liver failure,
- •History of convulsion,
- •Severe mental disorder
Investigators
Similar Trials
Completed
Phase 3
Comparison of naloxone and naltrexone in the treatment of methadone poisoning in patients referred to the emergency departmentPoisoning by methadone.IRCT2016100623552N11Vice Chancellor for research of Arak University of Medical Sciences80
Recruiting
Phase 3
The effect of naloxone on hemodynamic factors and bleeding rate in patients under general anesthesia.Head and neck surgery.Diffuse follicle center lymphoma, lymph nodes of head, face, and neckC82.51IRCT20101122005225N10Tehran University of Medical Sciences114
Completed
Phase 2
The effect of Naltrexone on memory deficit induced by Electroconvulsive therapyCondition 1: Depressive Episode. Condition 2: Memory deficit induced by electroconvulsive therapy.Depressive episodeIRCT2016060628309N1Vice chancellor for research,Shahid Beheshti University of Medical Sciences40
Active, not recruiting
Phase 1
To evaluate the effect of low-dose naltrexone (LDN) on pain perception and quality of life in womeEUCTR2022-000245-33-PLMedical University of Lublin300
Not yet recruiting
Phase 3
The effect of Ultra-low-dose Naloxone combined with Patient-Controlled-Analgesia Intravenous Morphine in Complex Spine Surgery: A Double blinded, Randomized Controlled TrialTCTR20221001003Faculty of Medicine, Chiang Mai University20